Tune in to this interdisciplinary expert roundtable discussion, which will highlight data from the American College of Rheumatology (ACR) 2023, spotlighting biosimilars.
This live session will be hosted by our expert chair Julie Ann Lough, who will be joined by Muhammad Nisar, Consultant Rheumatologist and Physician at Luton and Dunstable University Hospital NHS Foundation Trust, UK; Rieke Alten, Professor of Medicine at Department of Internal Medicine and Rheumatology, Schlosspark-Klinik, University Medicine Berlin, Germany; and Laurent Peyrin-Biroulet, INSERM Unité 954 and Department of Gastroenterology, Nancy University Hospital, France.
‘Key Insights from ACR 2023: An Interdisciplinary Expert Roundtable Discussion’ will spotlight:
– New mechanisms of action, trends, and data that emerged from ACR 2023
– New data on anti-TNFs and real-world evidence with biosimilars from ACR 2023
– New uses and data on adalimumab.
This exciting webinar will also include a question-and-answer section, in which our expert speakers will address key questions from the audience, providing specialist insight and perspective.
